Molecular Express and its collaborators have extensive relationships with scientists and researchers throughout the world. These investigators are in academic institutions and commercial settings alike, thus providing a unique interface between the academic, governmental, clinical and commercial disciplines.

The Company and its scientific team have significant experience in process development, documentation, scale-up and cGMP manufacturing, having been part of the team that invented, developed and scaled up the manufacturing of AmBiosome®, an anti-fungal which has generated sales of well over $1 billion in the marketplace.

Molecular Express currently has active research and development programs in the fields of infectious diseases, anti-cancer therapies and regenerative medicine.

Molecular Express believes in the power of shared vision, innovative ideas, and collaborative efforts.